FDAnews
www.fdanews.com/articles/134028-altair-therapeutics-shut-down-after-mid-stage-asthma-study-fails

Altair Therapeutics Shut Down After Mid-Stage Asthma Study Fails

February 4, 2011
San Diego-based Altair Therapeutics, a spinoff from Isis Pharmaceuticals, has shut down operations after the startup’s only drug candidate failed in a mid-stage clinical trial against asthma.
Xconomy